The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-Chloro-2-[4-(4-methylpiperazin-1-yl)phenoxy]phenol ID: ALA2347844
PubChem CID: 71579716
Max Phase: Preclinical
Molecular Formula: C17H19ClN2O2
Molecular Weight: 318.80
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(c2ccc(Oc3ccc(Cl)cc3O)cc2)CC1
Standard InChI: InChI=1S/C17H19ClN2O2/c1-19-8-10-20(11-9-19)14-3-5-15(6-4-14)22-17-7-2-13(18)12-16(17)21/h2-7,12,21H,8-11H2,1H3
Standard InChI Key: MZHIMYOTMBAACU-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
24.2708 -2.0925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2697 -2.9120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9777 -3.3210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6874 -2.9115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6845 -2.0889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9759 -1.6836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9735 -0.8664 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.5616 -3.3200 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
26.3907 -1.6776 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.1000 -2.0835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0997 -2.8984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8081 -3.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8006 -1.6694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5095 -2.0715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5125 -2.8914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2222 -3.2964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.2228 -4.1159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9285 -4.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6366 -4.1121 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6344 -3.2940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9242 -2.8846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3448 -4.5198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
2 8 1 0
5 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 15 2 0
14 13 2 0
13 10 1 0
14 15 1 0
15 16 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
19 22 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 318.80Molecular Weight (Monoisotopic): 318.1135AlogP: 3.59#Rotatable Bonds: 3Polar Surface Area: 35.94Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.46CX Basic pKa: 8.07CX LogP: 3.06CX LogD: 3.01Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.94Np Likeness Score: -0.86
References 1. Cheng G, Muench SP, Zhou Y, Afanador GA, Mui EJ, Fomovska A, Lai BS, Prigge ST, Woods S, Roberts CW, Hickman MR, Lee PJ, Leed SE, Auschwitz JM, Rice DW, McLeod R.. (2013) Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase., 23 (7): [PMID:23453069 ] [10.1016/j.bmcl.2013.02.019 ]